-
1
-
-
0027294709
-
Rationale for the use of clodronate in osteoporosis
-
Kanis JA, McCloskey EV, Sirtori P, Khan S, Fern D, Eyres K et al. Rationale for the use of clodronate in osteoporosis. Osteoporosis Int 1993;3 Suppl:23-8.
-
(1993)
Osteoporosis Int
, Issue.3 SUPPL.
, pp. 23-28
-
-
Kanis, J.A.1
McCloskey, E.V.2
Sirtori, P.3
Khan, S.4
Fern, D.5
Eyres, K.6
-
2
-
-
0030498005
-
Analgesic effect of biphosphonates on bone pain in breast cancer patients: A review article
-
Strang P. Analgesic effect of biphosphonates on bone pain in breast cancer patients: a review article. Acta Oncol 1996;35:50-90.
-
(1996)
Acta Oncol
, vol.35
, pp. 50-90
-
-
Strang, P.1
-
3
-
-
0035496754
-
Bisphosphonates in the treatment of metastatic breast cancer
-
Body JJ. Bisphosphonates in the treatment of metastatic breast cancer. J Mammary Gland Biol Neoplasia 2001;6:477-85.
-
(2001)
J Mammary Gland Biol Neoplasia
, vol.6
, pp. 477-485
-
-
Body, J.J.1
-
4
-
-
0034070907
-
Intravenous clodronate for acute pain induced by osteoporotic vertebral fracture
-
Rovetta G, Monteforte P, Balestra V. Intravenous clodronate for acute pain induced by osteoporotic vertebral fracture. Drugs Exp Clin Res 2000;26:25-30.
-
(2000)
Drugs Exp Clin Res
, vol.26
, pp. 25-30
-
-
Rovetta, G.1
Monteforte, P.2
Balestra, V.3
-
5
-
-
0032761540
-
Treatment of patients with Paget's disease of bone
-
Roux C, Dougados M. Treatment of patients with Paget's disease of bone. Drugs 1999;58:823-30.
-
(1999)
Drugs
, vol.58
, pp. 823-830
-
-
Roux, C.1
Dougados, M.2
-
6
-
-
0034080615
-
Intravenous clodronate in the treatment of reflex sympathetic dystrophy syndrome. A randomized, double blind, placebo controlled study
-
Varenna M, Zucchi F, Ghiringhelli D, Binelli L, Bevilacqua M, Bettica P et al. Intravenous clodronate in the treatment of reflex sympathetic dystrophy syndrome. A randomized, double blind, placebo controlled study. J Rheumatol 2000;27:1477-83.
-
(2000)
J Rheumatol
, vol.27
, pp. 1477-1483
-
-
Varenna, M.1
Zucchi, F.2
Ghiringhelli, D.3
Binelli, L.4
Bevilacqua, M.5
Bettica, P.6
-
7
-
-
0035012580
-
One-month follow-up of patients treated by intravenous clodronate for acute pain induced by osteoporotic vertebral fracture
-
Rovetta G, Maggiani G, Molfetta L, Monteforte P. One-month follow-up of patients treated by intravenous clodronate for acute pain induced by osteoporotic vertebral fracture. Drugs Exp Clin Res 2001;27:77-81.
-
(2001)
Drugs Exp Clin Res
, vol.27
, pp. 77-81
-
-
Rovetta, G.1
Maggiani, G.2
Molfetta, L.3
Monteforte, P.4
-
8
-
-
0033711724
-
Synovial macrophage depletion with clodronate-containing liposomes in RA
-
Valleala H, Friman C, Konttinen Y, Solovieva S, Teronen O, Sorsa T. Synovial macrophage depletion with clodronate-containing liposomes in RA. Arthritis Rheum 2000;43:1951-9.
-
(2000)
Arthritis Rheum
, vol.43
, pp. 1951-1959
-
-
Valleala, H.1
Friman, C.2
Konttinen, Y.3
Solovieva, S.4
Teronen, O.5
Sorsa, T.6
-
9
-
-
0033824938
-
High-dose clodronate therapy prevents joint destruction in chronic antigen-induced arthritis of the rat but inhibits bone formation at the axial skeleton
-
Oelzner P, Kunze A, Henzgen S, Thoss K, Hein G, Stein G et al. High-dose clodronate therapy prevents joint destruction in chronic antigen-induced arthritis of the rat but inhibits bone formation at the axial skeleton. Inflamm Res 2000;49:424-33.
-
(2000)
Inflamm Res
, vol.49
, pp. 424-433
-
-
Oelzner, P.1
Kunze, A.2
Henzgen, S.3
Thoss, K.4
Hein, G.5
Stein, G.6
-
10
-
-
0030894531
-
Slow-release clodronate in prevention of inflammation and bone loss associated with adjuvant arthritis
-
Osterman T, Virtamo T, Lauren L, Kippo K, Pasanen I, Hannuniemi R et al. Slow-release clodronate in prevention of inflammation and bone loss associated with adjuvant arthritis. J Pharmacol Exp Ther 1997;280:1001-7.
-
(1997)
J Pharmacol Exp Ther
, vol.280
, pp. 1001-1007
-
-
Osterman, T.1
Virtamo, T.2
Lauren, L.3
Kippo, K.4
Pasanen, I.5
Hannuniemi, R.6
-
11
-
-
0029053245
-
Effect of clodronate on established collagen-induced arthritis in rats
-
Osterman T, Kippo K, Lauren L, Hannuniemi R, Sellman R. Effect of clodronate on established collagen-induced arthritis in rats. Inflamm Res 1995;44:258-63.
-
(1995)
Inflamm Res
, vol.44
, pp. 258-263
-
-
Osterman, T.1
Kippo, K.2
Lauren, L.3
Hannuniemi, R.4
Sellman, R.5
-
12
-
-
0030897042
-
A comparison of clodronate and indomethacin in the treatment of adjuvant
-
Osterman T, Kippo K, Lauren L, Pasanen I, Hannuniemi R, Sellman R. A comparison of clodronate and indomethacin in the treatment of adjuvant. Arthritis Inflamm Res 1997;46:79-85.
-
(1997)
Arthritis Inflamm Res
, vol.46
, pp. 79-85
-
-
Osterman, T.1
Kippo, K.2
Lauren, L.3
Pasanen, I.4
Hannuniemi, R.5
Sellman, R.6
-
13
-
-
0035664888
-
Clinical and biochemical response to single infusion of clodronate in active RA: A double blind placebo controlled study
-
Valleala H, Laitinen K, Pylkkanen L, Konttinen YT, Friman C. Clinical and biochemical response to single infusion of clodronate in active RA: a double blind placebo controlled study. Inflamm Res 2001;50:598-601.
-
(2001)
Inflamm Res
, vol.50
, pp. 598-601
-
-
Valleala, H.1
Laitinen, K.2
Pylkkanen, L.3
Konttinen, Y.T.4
Friman, C.5
-
14
-
-
0035722808
-
Intramuscolar injection of disodium-clodronate in patients with RA. Two months open study
-
Rovetta G, Monteforte P, Molfetta L. Intramuscolar injection of disodium-clodronate in patients with RA. Two months open study. Minerva Med 2001;92:417-9.
-
(2001)
Minerva Med
, vol.92
, pp. 417-419
-
-
Rovetta, G.1
Monteforte, P.2
Molfetta, L.3
-
15
-
-
0035985848
-
Pathogenesis of bone erosions in RA
-
Goldring SR. Pathogenesis of bone erosions in RA. Curr Opin Rheumatol 2002;14:406-10.
-
(2002)
Curr Opin Rheumatol
, vol.14
, pp. 406-410
-
-
Goldring, S.R.1
-
16
-
-
0031226196
-
Human neutrophil collagenase MMP-8 in peri-implant sulcus fluid and its inhibition by clodronate
-
Teronen O, Konttinen YT, Lindqvist C, Salo T, Ingman T, Lauhio A et al. Human neutrophil collagenase MMP-8 in peri-implant sulcus fluid and its inhibition by clodronate. J Dent Res 1997;76:1529-37.
-
(1997)
J Dent Res
, vol.76
, pp. 1529-1537
-
-
Teronen, O.1
Konttinen, Y.T.2
Lindqvist, C.3
Salo, T.4
Ingman, T.5
Lauhio, A.6
-
17
-
-
0032732107
-
Liposomal clodronate eliminates synovial macrophages, reduces inflammation and ameliorates joint destruction in antigen-induced arthritis
-
Richards PJ, Williams AS, Goodfellow RM, Williams BD. Liposomal clodronate eliminates synovial macrophages, reduces inflammation and ameliorates joint destruction in antigen-induced arthritis. Rheumatology (Oxford) 1999;38:818-25.
-
(1999)
Rheumatology (Oxford)
, vol.38
, pp. 818-825
-
-
Richards, P.J.1
Williams, A.S.2
Goodfellow, R.M.3
Williams, B.D.4
-
18
-
-
0033711724
-
Synovial macrophage depletion with clodronate-containing liposomes in RA
-
Barrera P, Blom A, van Lent PL, van Bloois L, Beijnen JH, van Rooijen N et al. Synovial macrophage depletion with clodronate-containing liposomes in RA. Arthritis Rheum 2000;43:1951-9.
-
(2000)
Arthritis Rheum
, vol.43
, pp. 1951-1959
-
-
Barrera, P.1
Blom, A.2
Van Lent, P.L.3
Van Bloois, L.4
Beijnen, J.H.5
Van Rooijen, N.6
|